Judge To Rule On Purdue Pharma Bankruptcy Plan That Shields Sacklers

(Reuters) – A U.S. judge is expected to rule on Wednesday on OxyContin maker Purdue Pharma’s request to approve its bankruptcy reorganization plan that would shield the company’s Sackler family owners from future litigation over the opioid crisis. If U.S. Bankruptcy Judge Robert Drain approves the deal, which Purdue values at more than $10 billion, it would clear a path to resolve thousands of opioid lawsuits.-- More...